Navigation Links
close in Biological Technology

Nektar to Announce Financial Results for the Second Quarter of 2009 on Tuesday, August 4, 2009, After Close of U.S.-Based Financial Markets

SAN CARLOS, Calif., July 31 /PRNewswire-FirstCall/ -- Nektar Therapeutics (Nasdaq: NKTR ) will announce its financial results for the second quarter ended June 30, 2009 on Tuesday, August 4, 2009, after the close of U.S.-based financial markets. Howard Robin, president and chief execut...

Blue Marble Energy Corp. Announces Successful Close of Series A Financing

SEATTLE, July 15 /PRNewswire/ -- Blue Marble Energy Corp. announced today that it had closed its series A financing round. The infusion of capital assures the company of the resources to continue its ground-breaking development of technology that converts a wide variety of...

Icahn Indicates That Biogen Board Refuses To Close Polls

NEW YORK, June 3 /PRNewswire/ -- Carl Icahn announced today that Biogen is acting in its usual shareholder unfriendly way by manipulating the annual meeting of shareholders in order the prevent the votes that have been submitted from being counted. They are doing so in order to attempt to keep tw...

BioVex Raises $40 Million in First Close of Series F Financing

WOBURN, Mass., March 30 /PRNewswire/ -- BioVex Inc, a company developing new generation biologics for the treatment and prevention of cancer and infectious disease, announced today it has raised $40 million in the first close of a series F private financing. The placement was led by Forbion C...

Nektar to Announce Year-End 2008 Financial Results on Wednesday, February 25, 2009 After Close of U.S.-Based Financial Markets

SAN CARLOS, Calif., Feb. 11 /PRNewswire-FirstCall/ -- Nektar Therapeutics (Nasdaq: NKTR ) will announce its financial results for the fourth quarter and year ended December 31, 2008 on Wednesday, February 25, 2009, after the close of U.S.-based financial markets. Howard Robin, president and...

Aisling Capital Announces Close of US$650M Life Sciences Fund

NEW YORK, Jan. 7 /PRNewswire/ -- Aisling Capital announced today that it raised US$650 million in committed capital for its newest life sciences fund, Aisling Capital III, LP. Aisling Capital will invest its third fund primarily in companies developing pharmaceutical, biopharmaceutical and medical...

Nektar to Announce Financial Results for the Second Quarter of 2008 on Wednesday, August 6, 2008, After Close of U.S.-Based Financial Markets

SAN CARLOS, Calif., July 30 /PRNewswire-FirstCall/ -- Nektar Therapeutics (Nasdaq: NKTR ) will announce its financial results for the second quarter ended June 30, 2008 on Wednesday, August 6, 2008, after the close of U.S.-based financial markets. Howard Robin, president and chief executive o...

Nektar to Announce Q1 2008 Financial Results on Wednesday, May 7, 2008, After Close of U.S.-Based Financial Markets

SAN CARLOS, Calif., April 30 /PRNewswire-FirstCall/ -- Nektar Therapeutics (Nasdaq: NKTR ) will announce its financial results for the first quarter ended March 31, 2008 on Wednesday, May 7, 2008, after the close of U.S.-based financial markets. Howard Robin, president and chief executive off...

Plexus Q2 Earnings Release on April 23rd After Market Close and Conference Call on April 24th at 8:30 am E.T.

NEENAH, Wis., March 25 /PRNewswire-FirstCall/ -- Plexus Corp. (Nasdaq: PLXS), today announced it will release its fiscal 2008 second quarter results for the period ended March 29, 2008 on Wednesday, April 23rd after the stock market closes. Senior management will host a live webcast and confer...

Plexus Q2 Earnings Release on April 23rd After Market Close and Conference Call on April 24th at 8:30 am E.T.

NEENAH, Wis., March 25 /PRNewswire-FirstCall/ -- Plexus Corp. (Nasdaq: PLXS), today announced it will release its fiscal 2008 second quarter results for the period ended March 29, 2008 on Wednesday, April 23rd after the stock market closes. Senior management will host a live webcast and confer...

Inverness Medical Innovations to Close Cholestech, HemoSense and BioStar Facilities

WALTHAM, Mass., March 18 /PRNewswire-FirstCall/ -- Inverness Medical Innovations, Inc. (Amex: IMA ), a leading manufacturer and marketer of rapid diagnostic products for the consumer and professional markets, announced today that as part of its continuing efforts to streamline its worldwide o...

Genmab and PDL BioPharma Close Sale of Antibody Manufacturing Facility

Summary: Genmab's Acquisition of PDL BioPharma's Antibody Manufacturing Facility has Closed. COPENHAGEN, Denmark and REDWOOD CITY, California, March 14 /PRNewswire-FirstCall/ -- Genmab A/S (OMX: GEN) and PDL BioPharma, Inc. (Nasdaq: PDLI ) today announced the closing ...

Otsuka Pharmaceutical and PDL BioPharma Close Sale of IV Busulfex

PRINCETON, N.J., TOKYO, and REDWOOD CITY, Calif., March 10 /PRNewswire-FirstCall/ -- Otsuka Pharmaceutical Co., Ltd. (OPC) and PDL BioPharma, Inc. (Nasdaq: PDLI ) today announced the closing of the previously announced transaction under which Otsuka has acquired PDL's rights to IV Busulfex(R)...

Peptimmune Announces First Close of Series D Private Financing

CAMBRIDGE, Mass., Jan. 17 /PRNewswire/ -- Peptimmune, Inc., a privately held biotechnology company, announced that it has completed a first close of $8.2 million of a Series D preferred stock offering with its investor syndicate led by New Enterprise Associates, MPM Capital, Hunt Ventures L.P....

LineaGen Inc. Launches With Close of $5.8 Million Series A Funding Round

Led by world-class management team, board and scientific research collaborators, LineaGen is leveraging new funding round, Utah Population Database, and other key resources to advance Utah's proven biomarker discovery platform for commercializing first-in-class molecular diagnostic ...

Abiant, Inc. Announces Close on Investment Round

CHICAGO, Oct. 1 /PRNewswire/ -- Abiant, Inc., an Illinois based company specializing advanced bio-imaging to accelerate and improve drug development and disease diagnosis, announces the successful closing of a $600,000 private placement. Lead investor Heartland Angels, an angel network special...

DMV to close Monday for computer upgrade

The Department of Motor Vehicles in Wisconsin plans to close all its offices on December 13 for the end of a system-wide computer upgrade. The new system, which has been in development for the past week, will combine registration and driver records to make searches faster and add newer programming ...

National stem-cell panel, including UW profs, urges close watch on research

Research institutions should create oversight committees to guide human embryonic stem-cell studies according to common guidelines, a panel of experts, including two University of Wisconsin-Madison professors, said on Tuesday in Washington, D.C. "In the absence of federal guidelines broadly gove...

Schering-Plough Shareholders Approve Merger With Merck

...e will continue to focus on driving our business and advancing our strong late-stage pipeline until closing." The merger, which is expected to close in the 2009 fourth quarter, is subject to the satisfaction of customary closing conditions and regulatory approvals, including expiration or terminati...

Onyx Pharmaceuticals Announces Pricing of Concurrent Offerings of Four Million Shares of Common Stock and $200 Million Principal Amount of Convertible Senior Notes

...ferings by means of separate prospectus supplements, and neither of these offerings is contingent upon the consummation of the other. Onyx expects to close the transactions on or about August 12, 2009, and each closing is subject to the satisfaction of customary closing conditions. These offering...

deCODE genetics Announces Webcast of Conference Call to Discuss Second Quarter 2009 Financial Results

... DCGN ) today announced that it will report its second quarter 2009 financial results in a press release to be issued on Monday, August 10, after the close of the market in New York. The company will host a live webcast of its conference call to discuss these results and recent operating highlights on Tue...

Oncothyreon announces webcast of second quarter 2009 financial results conference call

...t of cancer, today announced that it intends to release its second quarter and year end 2009 financial results on Wednesday, August 12, 2009 after the close of the U.S. and Canadian markets. Following the release, Oncothyreon's management expects to discuss these financial results and give a general busine...

New clues about a hydrogen fuel catalyst

...lated data with real data gathered about the catalyst. The two sets of data matched very well, suggesting the structure they had come up with was very close to reality. The chemical nature of the structure, along with additional experimental data, allowed the team to outline the chemical reaction occur...

Idenix Pharmaceuticals Prices Underwritten Offering of Common Stock

..., the company expects to receive net proceeds of approximately $21.2 million. All of the shares are being sold by Idenix. The offering is expected to close on August 10, 2009, subject to customary closing conditions. The shares will be issued pursuant to a shelf registration statement on Form S-3 p...

Shire plc: Core Portfolio of Products Delivers 20% Sales Growth

...US cents per ADS (2008: 6.441 US cents) will be paid on October 8, 2009 to persons whose names appear on the register of members of the Company at the close of business on September 11, 2009. Additional Information The following additional information is included in this press release: ...

Pharmacyclics, Inc. Rights Offering Oversubscribed

...,750,000 shares to up to 22,500,000 shares. The subscription agent has informed the Company that based on a preliminary tabulation, as of the close of the offering the Company had received valid subscriptions from approximately 375 participants for the purchase of in excess of the 22,500,000 share...

Angiotech Pharmaceuticals announces launch of Quill SRS product codes for laparoscopic gynecology procedures

...whether performed manually by surgeons or through robotic assistance. The primary advantage of Quill SRS for laparoscopic procedures is the ability to close a wound using Quill without the surgeon having to tie knots. The exercise of tying knots can be very challenging and time consuming when surgeons are ...

Revised: Sinovac Provides Update on Clinical Trial for H1N1 Vaccine Trials

...enter for Disease Control (CDC), and undertaken by Beijing CDC. The Ministry of Health (MOH) and State Food and Drug Administration (SFDA) are paying close attention to this clinical trial. Deputy Director General of MOH Disease Control Department, Donglou Xiao, Director of SFDA Registration Section, Wei...

Advanced Life Sciences Receives Complete Response Letter From FDA for Restanza(TM) (Cethromycin) in Community Acquired Pneumonia

...terest in seeing the Company pursue further development. We continue to receive strong support from our commercial partner Wyeth and intend to work in close collaboration with them as we implement our clinical program. We believe that Restanza has significant therapeutic and commercial potential as a novel...

CuraGen Reports Second Quarter 2009 Financial Results

...56 per fully diluted share, to between $93.5 million and $94.0 million or $1.54 - $1.55 per fully diluted share. The proposed merger is projected to close in the third quarter of 2009. Forward-Looking Statements Statements in this press release regarding management's future expectations, beli...

TorreyPines Cancels Special Meeting of Stockholders in Order to Pursue Merger Transaction

...ard-looking statements or predictions. Such forward-looking statements include, but are not limited to, the following statements: that the merger will close in the fourth quarter of 2009, if at all; that the combined company will list on the Nasdaq Capital Markets or any national exchange; that TorreyPines...

Trubion Announces Dates for Second Quarter and First Half 2009 Earnings Conference Call

...ls Inc. (Nasdaq: TRBN ) today announced that it plans to issue earnings results for its second quarter and six months ended June 30, 2009, after the close of market on Aug. 6, 2009. The company's earnings conference call will take place Aug. 6, 2009 at 2 p.m. Pacific Time, 5 p.m. Eastern Time. (L...

Amicus Therapeutics Announces Second Quarter 2009 Financial Results Release Date

...Y, N.J., July 29 /PRNewswire-FirstCall/ -- Amicus Therapeutics (Nasdaq: FOLD ) will announce second quarter 2009 financial results after the regular close of markets on Wednesday, August 5, 2009. The results announcement will be followed by a live conference call and webcast that afternoon at 5 p.m. EDT....

Sanofi-aventis Announces Second Quarter 2009 Results

... compared with the performance measure currently used by sanofi-aventis. Growth in 2009 net income measured using this new indicator will therefore be close to growth in "Adjusted net income excluding selected items". About sanofi-aventis Sanofi-aventis U.S. is an affiliate of sanofi-aventis, a ...

Human Genome Sciences Announces Pricing of Public Offering of Common Stock

... granted the underwriters a 30-day option to purchase up to an additional 3,482,250 shares of the Company's common stock. The offering is expected to close on August 3, 2009, subject to customary closing conditions. The Company anticipates net proceeds from the offering of approximately $310 million. ...

Poniard Pharmaceuticals to Host Second Quarter 2009 Financial Results Conference Call on August 4

...inning at 4:30 p.m. Eastern time (1:30 p.m. Pacific time). A press release for the second quarter ended June 30, 2009, will be released after markets close on August 4. To participate in the live call by telephone, please dial 888-515-2880 (United States) or 719-457-2652 (International). In addit...

Cell Therapeutics, Inc. Announces Exercise of Overallotment

...are exercisable immediately upon the date of issuance and will expire nine months thereafter. As previously announced, the Company expects to close the offering on or about July 28, 2009, subject to customary conditions, at which time the Company will receive the cash proceeds from the offering an...

Cell Therapeutics, Inc. Announces Pricing of Public Offering of Common Stock and Warrants

... warrants. The warrants are exercisable immediately upon the date of issuance and will expire nine months thereafter. The Company expects to close the offering on or about July 28, 2009, subject to customary conditions, at which time the Company will receive the cash proceeds from the offering an...

University of Lodz Invests in the Unique Cellaxess(R)HT System for Research on Multidrug Resistance Genes in Cancer

...am demonstrates the capabilities of this state-of-the-art system designed for genomic research and screening. Cellectricon has developed the system in close collaboration with leading research groups and leading pharmaceutical companies to meet the increasing demand for a generic technology capable of true...

Human Genome Sciences Announces New Order for Raxibacumab (ABthrax(TM)) from U.S. Government

... of life. With raxibacumab, the United States now has a treatment for inhalation anthrax. It has taken HGS nearly seven years of work, much of it in close partnership with BARDA, to reach the point where we have successfully delivered raxibacumab to the Stockpile and secured this second purchase order. ...
Other Tags
(Date:3/16/2015)... 2015 Between 16 and ... groundbreaking innovations in biometric identification at the CeBIT ...      (Photo: http://photos.prnewswire.com/prnh/20150316/735333 ) ... well at the forefront: the company,s all new ... Germany . BiometricGate is the ...
(Date:3/11/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/3p32qm/access_control ... Control Market by Product, Application & By Geography - ... their offering. , This report predicts that ... billion by 2020, with an estimated CAGR of 10.6%. ... products types such as contact cards & readers, contactless ...
(Date:3/10/2015)... 10, 2015  NXT-ID, Inc. (NASDAQ: ... a biometric authentication company focused on the growing ... wallet has been named the "Number One Best ... Rethink Modern ( http://www.rethinkmodern.com/ ) is a ... home and lifestyle that have a unique function or ...
Breaking Biology News(10 mins):DERMALOG Presents its Latest Biometric Innovations at the Hannover CeBIT Exhibition, 16 - 20 March 2015 2DERMALOG Presents its Latest Biometric Innovations at the Hannover CeBIT Exhibition, 16 - 20 March 2015 3Global Access Control (Cards & Readers, Biometrics, Controllers, Management Software) Market 2015-2020 - Analysis of the $10 Billion Market 2NXT-ID's Wocket Smart Wallet Named Number One Best Tech Gift for 2015 by Rethink Modern 2NXT-ID's Wocket Smart Wallet Named Number One Best Tech Gift for 2015 by Rethink Modern 3NXT-ID's Wocket Smart Wallet Named Number One Best Tech Gift for 2015 by Rethink Modern 4
(Date:3/26/2015)... “The SWEET Act is an important step ... available and help parents who are working to reduce sugar ... approach to support public health, and we will continue to ... health of all families,” said Dr. Jane Delgado President and ... introduction of the Sugar-Sweetened Beverage Tax (SWEET) Act by Congresswoman ...
(Date:3/26/2015)... 26, 2015 The Life Support ... to Hyperbaric Medicine” course, which is accredited by ... and the National Board of Diving & Hyperbaric ... course 4 times a year at several of ... tri-state region; registration is available on-line at: ...
(Date:3/26/2015)... The National League for Nursing, and ... has announced its partnership with Questionmark®, a supplier ... to accurately and securely measure knowledge, skills, and ... Questionmark’s state-of-the-art software and a custom-built portal, ... of the seventy-five to one hundred thousand exams ...
(Date:3/26/2015)... 26, 2015 In preparation for the ... Revolution, founded by Samir Becic, has issued “report ... personal health and fitness, as well as their promotion ... list includes Sen. Ted Cruz, who has officially announced ... all other politicians who have shown interest in running ...
(Date:3/26/2015)... 26, 2015 Zane Benefits, the leader ... a new eBook, “The Comprehensive Guide To Interviewing For ... is the most important aspect of the hiring process. ... hiring the right way, possibly resulting in thousands of ... arduous undertaking, yet it’s essential to the success of ...
Breaking Medicine News(10 mins):Health News:National Alliance for Hispanic Health Statement on Introduction of SWEET Act in 114th Congress 2Health News:The Life Support Technologies Group (LST) Conducted its 30th Accredited “Introduction to Hyperbaric Medicine” Course for Health Care Professionals 2Health News:The Life Support Technologies Group (LST) Conducted its 30th Accredited “Introduction to Hyperbaric Medicine” Course for Health Care Professionals 3Health News:The Life Support Technologies Group (LST) Conducted its 30th Accredited “Introduction to Hyperbaric Medicine” Course for Health Care Professionals 4Health News:NLN Testing Services Announces Improved Delivery and Analytics Software and Newly Developed and Revised Exams 2Health News:How the Candidates for the 2016 Presidential Election Rank in Health and Fitness 2Health News:How the Candidates for the 2016 Presidential Election Rank in Health and Fitness 3Health News:Zane Benefits Announces: New eBook: The Comprehensive Guide To Interviewing For Your Small Business 2
Other Contents